Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07291245 · ClinicalTrials.gov registry record · NA

Kawasaki MATCH Trial

A NA study of Kawasaki Disease, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT07291245: Recruiting NA study of Kawasaki Disease, sponsored by University of California, San Diego.

NCT07291245 is a NA study of Kawasaki Disease that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07291245, a NA study of Kawasaki Disease, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

Evaluating the impact of a machine-learning clinical decision support tool on provider practice when evaluating febrile patients with Kawasaki Disease (KD) and non-KD illnesses.

Primary Outcome

Time in days from initial ED evaluation to initial IVIG treatment in patients ultimately diagnosed with Kawasaki Disease

Conditions Studied

Interventions

  • OTHER Kawasaki MATCH

Study Locations (1)

California

  • Rady Children's Hospital, San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-03-01
Est. Completion 2026-10-31
Phase NA
University of California, San Diego

775 total trials

What NCT07291245 shows while recruiting

NCT07291245 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Kawasaki Disease appearing as the primary indexed condition, and to 1 intervention - of which Kawasaki MATCH is the first listed.

NCT07291245 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07291245 about?

NCT07291245 is a clinical study titled "Kawasaki MATCH Trial". Evaluating the impact of a machine-learning clinical decision support tool on provider practice when evaluating febrile patients with Kawasaki Disease (KD) and non-KD illnesses.

What is the current status of trial NCT07291245?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-03-01. Estimated completion is 2026-10-31.

What conditions does trial NCT07291245 study?

This clinical trial studies the following conditions: Kawasaki Disease.

What interventions are being tested in trial NCT07291245?

The interventions under investigation include: Kawasaki MATCH (OTHER).

Who is sponsoring clinical trial NCT07291245?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07291245 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kawasaki Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07291245's enrollment target sits among peer trials

200 506th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07291245, the US trial registry maintained by the National Library of Medicine. NCT07291245 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.